Formulation and in vitro evaluation of theophylline-Eudragit® sustained-release tablets

Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences

Volumn 41, Issue 3, 2005, Pages 377-384

  Ojoe, Evelyn ^a   Miyauchi, Edna Mitie ^a   Viviani, Tais Cobo ^a   Consiglieri, Vladi Olga ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Dissolution; Matrices; Methacrylic acid esters; Sustained release; Theophylline

Indexed keywords

CALCIUM PHOSPHATE; DILUENT; EUDRAGIT; LACTOSE; LUBRICATING AGENT; MAGNESIUM STEARATE; PANCREATIN; PEPSIN A; THEOPHYLLINE;

ARTICLE; DRUG FORMULATION; DRUG RELEASE; IN VITRO STUDY; INTESTINE FLUID; PHYSICAL CHEMISTRY; STOMACH JUICE; SUSTAINED RELEASE PREPARATION;

EID: 32844474150     PISSN: 15169332     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-93322005000300011     Document Type: Article

References (13)

1. ACEVEZ, J. M.; CRUZ, R.; HERNANDES, E. Preparation and characterization of furosemide-Eudragit controlled-release systems. Int. J. Pharm., v. 195, p. 45-53, 2000.
2. CHAMBIN, O.; CHAMPION, D.; DEBRAY, C.; ROCHATGONTIER, M. H.; Le MESTE, M.; POURCELOT, Y. Effects of different cellulose derivatives on drug release mechanism studied at a preformulation stage. J. Control. Release, v. 95, p. 101-108, 2004.
3. EUDRAGIT® sustained-release formulations for oral dosage forms. Röhm Pharma. Basic Info 2/E. [Catalog], 2003.
4. FARMACOPÉIA Brasileira 4.ed. São Paulo: Atheneu, 1988. v.1, p. V-1.5.
5. HENDELES, L.; WEINBERGER, M.; JOHNSON, G. Monitoring serum theophylline levels. Clin. Pharmacokinet., v. 3, p. 294-312, 1978.
6. MONTPLAISIR, J.; WALSH, J.; MALO, J.L. Nocturnal asthma: features of attacks, sleep and breathing patterns. Am. Rev. Respir. Dis., v.125, p.18-22, 1982.
7. NELSON H.S. Adrenergic therapy of bronchial asthma. J Allergy Clin. Immunol., v.77, p.771-785, 1986.
8. OJOE, E.; MIYAUCHI, E. M.; SAKUDA, T. M.; VELASCO, M. V.; CONSIGLIERI, V. O. Studies on controlled-release of theophylline from matrix tablet formulation. Rev. Bras. Ciênc. Farm., v. 39, supl. 3, p. 204-207, 2003.
9. PATHER, S.I.; RUSSEL, I.; SYCE, J.A.; NEAU, S.H. Sustained release theophylline by direct compression. Part I. Formulation and in vitro testing. Int. J. Pharm. Kansas City, USA, v. 164, p.1-10, 1998.
10. ROBINSON, J.R.; ERIKSEN, S.P. Theoretical formulation of sustained-release dosage forms. J. Pharm. Sci., Washington, v.55, 11, p. 1254-1263, 1966.
11. SALOMON, J. L.; DOELKER, E. Formulation des comprimes à liberation prolongee I. Matrices inertes. Pharm. Acta Helv., Zurich, v. 55, p. 174-182, 1980.
12. TURNER-WARWICK, M. Asthma: A Nocturnal Disease: Epidemiology of nocturnal asthma. London, United Kingdom. Am. J. Med. v. 85, 1, (suppl 2), p. 6-8, 1988.
13. UNITED States pharmacopoeia. 25.ed. Rockville: United States Pharmacopeial Convention, 2002. p. 1684-1686.